✦ LIBER ✦

544 Predicting Response to Infliximab in Crohn's Disease: Role of CRP, MR Enterography and NOD2 Genotype

✍ Scribed by Finlay A. Macrae; Gregor J. Brown; Paula Lewis; Bernadette Viney; Cathy Pizzey; Zina Valaydon; Damien Stella; Robert N. Gibson; Kaye E. Marion

Book ID: 119431190
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 43 KB
Volume: 138
Category: Article
ISSN: 0016-5085
DOI: 10.1016/s0016-5085(10)60339-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Letter of Response to Article: Preoperat

Letter of Response to Article: Preoperative Magnetic Resonance Enterography in Predicting Findings and Optimizing Surgical Approach in Crohn’s Disease

✍ Morar, Pritesh; Bagnall, Nigel Mark; Faiz, Omar 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 81 KB

25 Influence of NOD2 Genotype on the Mod

25 Influence of NOD2 Genotype on the Modulatory Effect of Vitamin D on NOD2 and TLR- Induced Cytokine Responses in Crohn's Disease

✍ Dionne, Serge; Adelson, Brandon A.; Piccirillo, Ciriaco; Bitton, Alain; Seidman, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Antimicrobial peptide response to blood

Antimicrobial peptide response to blood translocation of bacterial DNA in Crohn's disease is affected by NOD2/CARD15 genotype

✍ Ana Gutiérrez; Ernst Holler; Pedro Zapater; Laura Sempere; Rodrigo Jover; Miguel 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Background: Blood translocation of bacterial-DNA has been described in patients with Crohn's disease (CD). The host's immune cell types cooperate to respond against bacterial insults. Some antimicrobial peptides are inducible after culture with bacterial products and a linkage has been established b

Smoking, age, duration of disease, gende

Smoking, age, duration of disease, gender, and other clinical factors do not predict response to infliximab in Crohn's disease patients

✍ Fefferman, David S.; Lodhavia, Parag J.; Reinert, Steven; Hani, Abdallah; Falchu 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Normal responses to specific NOD1-activa

Normal responses to specific NOD1-activating peptidoglycan agonists in the presence of the NOD2 frameshift and other mutations in Crohn's disease

✍ David A. van Heel; Karen A. Hunt; Subrata Ghosh; Mireille Hervé; Raymond J. Play 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

Safety and Efficacy of Adalimumab (D2E7)

Safety and Efficacy of Adalimumab (D2E7) in Crohn's Disease Patients with an Attenuated Response to Infliximab

✍ Papadakis, Konstantinos A.; Shaye, Omid A.; Vasiliauskas, Eric A.; Ippoliti, And 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 80 KB